HRID 2172175As product
Completing data — refresh the page later to see the latest
258818-34-7CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)CORFLZNAGUTZRLQ-ZMBVWFSWSA-NLarazotide is an oligopeptide.
AT-1001 is an orally administered octapeptide zonulin receptor antagonist that appears to exert its inhibitory effect on gliadin-induced tight junction disassembly by blocking putative zonulin receptors on the luminal surface of the small intestine.
UsesLarazotideis a peptide which is an orally active zonulin antagonist. Larazotide shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide can be used for the research of celiac disease and infection[1][2].
DefinitionChEBI: Larazotide is an oligopeptide.
258818-34-7DTXSID30180526CHEMBL2105646CHEBI:177799